ESSA Pharma Stock Performance

Stocks . USA . 
Stock . ESSA Pharma
EPIX Stock  USD 2.97  0.08  2.62%   
On a scale of 0 to 100, ESSA Pharma holds a performance score of 8. The firm shows a Beta (market volatility) of 1.3016, which means a somewhat significant risk relative to the market. Let's try to break down what ESSA Pharma's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ESSA Pharma will likely underperform. Although it is vital to follow ESSA Pharma historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The approach towards predicting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating ESSA Pharma technical indicators, you can now evaluate if the expected return of 0.41% will be sustainable into the future. Please utilizes ESSA Pharma potential upside, as well as the relationship between the accumulation distribution and price action indicator to make a quick decision on whether ESSA Pharma price patterns will revert.
  

ESSA Pharma Performance

8 of 100

Compared to the overall equity markets, risk-adjusted returns on investments in ESSA Pharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, ESSA Pharma showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
1:20
Dividend Date
2018-04-25
Last Split Date
2018-04-25
1
EPS Estimate12/30/2022
2
Sale by Franklin Berger of 43617 shares of ESSA Pharma01/05/2023
3
Pharvaris Provides Regulatory, Clinical, and Corporate Updat...01/09/2023
4
A Look At The Fair Value Of ESSA Pharma Inc.01/25/2023
5
ESSA Pharma Inc expected to post a loss of 23 cents a share ...01/30/2023
6
ESSA Pharma Scheduled to Post Earnings on Friday02/02/2023
7
EPS Reported02/07/2023
8
Unclassified Event02/09/2023
9
ESSA Pharma Announces Presentations at the American Society ...02/13/2023
10
EPIX Deep and Sustained PSA Responses in Phase 12 Combinatio...02/23/2023
11
ESSA Pharma to Present at the Oppenheimer 33rd Annual Health...03/08/2023
12
Filing03/10/2023
Begin Period Cash Flow137.8 M
Free Cash Flow-28.7 M

ESSA Pharma Relative Risk vs. Return Landscape

If you would invest  242.00  in ESSA Pharma on December 23, 2022 and sell it today you would earn a total of  55.00  from holding ESSA Pharma or generate 22.73% return on investment over 90 days. ESSA Pharma is currently generating 0.4119% in daily expected returns and assumes 3.7897% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than ESSA Pharma, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days ESSA Pharma is expected to generate 3.93 times more return on investment than the market. However, the company is 3.93 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.05 per unit of risk.

ESSA Pharma Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for ESSA Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ESSA Pharma, and traders can use it to determine the average amount a ESSA Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1087

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsEPIX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.79
  actual daily
 33 
67% of assets are more volatile
3333

Expected Return

 0.41
  actual daily
 8 
92% of assets have higher returns
88

Risk-Adjusted Return

 0.11
  actual daily
 8 
92% of assets perform better
88
Based on monthly moving average ESSA Pharma is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ESSA Pharma by adding it to a well-diversified portfolio.

ESSA Pharma Fundamentals Growth

ESSA Pharma Stock prices reflect investors' perceptions of the future prospects and financial health of ESSA Pharma, and ESSA Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ESSA Pharma Stock performance.
Return On Equity(0.19) %
Return On Asset(0.13) %
Current Valuation(35.25 M)
Shares Outstanding44.09 M
Price to Earning(1.12) X
Price to Book0.79 X
EBITDA(35.08 M)
Net Income(35.1 M)
Cash and Equivalents174.6 M
Cash per Share3.96 X
Total Debt242.14 K
Debt to Equity0.001 %
Current Ratio43.43 X
Book Value Per Share3.67 X
Cash Flow from Operations(28.7 M)
Earnings Per Share(0.74) X
Market Capitalization131.4 M
Total Asset169.51 M
Retained Earnings(50.63 M)
Working Capital6.39 M
Current Asset10.02 M
Current Liabilities3.63 M

About ESSA Pharma Performance

To evaluate ESSA Pharma Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ESSA Pharma generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ESSA Pharma Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ESSA Pharma market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ESSA Pharma's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Effect of Exchange Rate Changes on Cash59 K63.6 K
Return on Average Assets(0.22) (0.24) 
Return on Average Equity(0.23) (0.25) 
Return on Invested Capital(0.43) (0.47) 

Things to note about ESSA Pharma performance evaluation

Checking the ongoing alerts about ESSA Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ESSA Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ESSA Pharma has very high historical volatility over the last 90 days
Net Loss for the year was (35.1 M) with profit before overhead, payroll, taxes, and interest of 0.
ESSA Pharma currently holds about 174.6 M in cash with (28.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
ESSA Pharma has a frail financial position based on the latest SEC disclosures
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference
Evaluating ESSA Pharma's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ESSA Pharma's stock performance include:
  • Analyzing ESSA Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ESSA Pharma's stock is overvalued or undervalued compared to its peers.
  • Examining ESSA Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ESSA Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ESSA Pharma's management team can help you assess the company's leadership.
  • Pay attention to analyst opinions and ratings of ESSA Pharma's stock. These opinions can provide insight into ESSA Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ESSA Pharma's stock performance is not an exact science, and many factors can impact ESSA Pharma's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Investing Opportunities. For more information on how to buy ESSA Pharma Stock please use our How to Invest in ESSA Pharma guide. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for analysis

When running ESSA Pharma price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA Pharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.74) 
Return On Assets
(0.13) 
Return On Equity
(0.19) 
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA Pharma that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine ESSA Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY